PhD+ Commercialization 7: Staging Risk & Capitalization

This is the seventh session of PhD Plus Commercialization skills series. 

How do investors “tease out” the risk/uncertainties when funding early-stage companies? And, what might be the consequences for founders and early investors as the company transitions through as series of funding rounds in order to grow? A case providing the early history of the relationship between Genentech and VC Kleiner Perkins will provide the story supporting our discussion.

:: PLEASE READ ::

Feld, B. (2004). Venture capital deal algebra. Feld Thoughts, July 7, 2004.

INSTRUCTOR

David Touve, Senior Director, Applied Innovations and New Ventures, Batten Institute, Darden School of Business

REGISTRATION

Please register to receive the zoom link and email reminders.